Patent Ductus Arteriosus. Patent ductus arteriosus
Conditions
Interventions
Experiment group included infants who were not treated through taking oral ibuprophen twice a day and were checked to be treated through taking oral acetaminophen with dose of 15 mg/kg every 6 hours f
Treatment - Drugs
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Months to No maximum
Inclusion criteria
Inclusion criteria: Inclusion: infants with contraindication using ibuprophen (oliguria: output less than 1cc/kg/hr. plackets less than 50000. Hyperbilirubinemia with the need to jaundice. Necrotizing enterocolitis perforation of the gastrointestinal tract); infants who were not treated through taking oral ibuprophen twice a day; infants with PDA determined by echocardiography. Exclusion: Congenital heart disease with the need to PDA to keep blood flow constant; life threatening infection; Intraventricular hemorrhage at 3 and 4 grades.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patent or closure of Ductus Arteriosus. Timepoint: By a doctor. Method of measurement: At the beginning of the intervention and three after that. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed